Review article: Autoimmune pancreatitis - Management of an emerging disease

Alimentary Pharmacology and Therapeutics

Volumn 33, Issue 3, 2011, Pages 291-303

  Kalaitzakis, E ^a   Webster, G J M ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G4; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ABDOMINAL PAIN; ASPIRATION BIOPSY; AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; BILIARY TRACT DISEASE; CHOLANGITIS; COMMUNICABLE DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ACTIVITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GLUCOSE TOLERANCE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; LOW DRUG DOSE; LYMPHADENOPATHY; MAINTENANCE THERAPY; MONOTHERAPY; OBSTRUCTIVE JAUNDICE; OSTEOPOROSIS; PANCREAS BIOPSY; PANCREAS CANCER; PANCREATITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; REVIEW; SEROLOGY; SIDE EFFECT; TREATMENT INDICATION; WEIGHT REDUCTION;

AUTOIMMUNE DISEASES; HUMANS; IMMUNOGLOBULIN G; PANCREATITIS; REMISSION INDUCTION; STEROIDS;

EID: 78650868842     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04526.x     Document Type: Review

References (79)

1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
2. Hirano K, Shiratori Y, Komatsu Y, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol 2003; 1: 453-64.
3. Kamisawa T, Funata N, Hayashi Y,. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of IgG4-related systemic disease. Am J Surg Pathol 2004; 28: 1114.
4. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A,. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006; 6: 132-7.
5. Kamisawa T, Okamoto A,. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25. (Pubitemid 44288524)
6. Sarles H, Sarles JC, Muratore R, Guien C,. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-98.
7. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N,. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561-8.
8. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo clinic experience. Clin Gastroenterol Hepatol 2006; 4: 1010-6.
9. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102: 2417-25.
10. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009; 104: 2288-94.
11. Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1229-34.
12. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344: 732-8.
13. Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A,. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005; 5: 234-8.
14. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009; 104: 2295-306.
15. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009; 38: 849-66.
16. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK,. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99: 1605-16.
17. Uchida K, Okazaki K, Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000; 95: 2788-94.
18. Song Y, Liu QD, Zhou NX, Zhang WZ, Wang DJ,. Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol 2008; 14: 601-6.
19. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233: 345-52.
20. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N,. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98: 2694-9.
21. Nakazawa T, Ohara H, Sano H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007; 65: 99-108.
22. Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010; 8: 91-6.
23. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S,. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41: 1197-205.
24. Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 2009; 76: 228-38.
25. Okazaki K, Uchida K, Matsushita M, Takaoka M,. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007; 42 (Suppl. 18): 32-8.
26. Takahashi N, Kawashima A, Fletcher JG, Chari ST,. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007; 242: 791-801.
27. Taniguchi T, Hamasaki A, Okamoto M,. A case of suspected lymphocytic hypophysitis and organizing pneumonia during maintenance therapy for autoimmune pancreatitis associated with autoimmune thrombocytopenia. Endocr J 2006; 53: 563-6.
28. Ando N, Yasuda I, Saito M, Moriwaki H,. Hilar lymphadenopathy associated with autoimmune pancreatitis. Pancreas 2006; 33: 101-2.
29. Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K,. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46: 463-71.
30. Wong S, Lam WY, Wong WK, Lee KC,. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 2007; 38: 1720-3.
31. Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 2008; 58: 118-25.
32. Bjornsson E, Chari ST, Smyrk TC, Lindor K,. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007; 45: 1547-54.
33. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134: 706-15.
34. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30: 76-82.
35. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004; 60: 937-44.
36. Hirano K, Kawabe T, Yamamoto N, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2006; 367: 181-4.
37. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 101: 2070-5.
38. Park DH, Kim MH, Chari ST,. Recent advances in autoimmune pancreatitis. Gut 2009; 58: 1680-9.
39. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008; 43: 403-8.
40. Kamisawa T, Imai M, Yui Chen P, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008; 37: e62-7.
41. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7: 1097-103.
42. Sugumar A, Levy MJ, Kamisawa T, et al. Utility of endoscopic retrograde pancreatogram to diagnose autoimmune pancreatitis: an international, double blind, randomized, multicenter study. Gut 2010 [Accepted for publication].
43. Okazaki K, Uchida K, Chiba T,. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001; 36: 293-302.
44. Kubota K, Iida H, Fujisawa T, et al. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis. Gastrointest Endosc 2007; 66: 1142-51.
45. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid therapy for autoimmune pancreatitis. Gut 2009; 58: 1504-7.
46. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007; 56: 1719-24.
47. Moon SH, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57: 1704-12.
48. Sugumar A, Chari ST,. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 2009; 7 (Suppl. 11): S59-62.
49. Shimosegawa T,. Are glucocorticoids really useful for the treatment of acute pancreatitis? J Gastroenterol 2002; 37: 580-1.
50. Rutz HP,. Effects of corticosteroid use on treatment of solid tumours. Lancet 2002; 360: 1969-70.
51. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K,. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006; 45: 497-501.
52. Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N,. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol 2008; 43: 609-13.
53. Matsushita M, Yamashina M, Ikeura T, et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol 2007; 102: 220-1.
54. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A,. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004; 39: 1154-8.
55. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007; 42 (Suppl. 18): 50-8. (Pubitemid 46863938)
56. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7: 1089-96.
57. Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol 2009; 7 (Suppl. 11): S18-22.
58. Sugumar A, Levy MJ, Kamisawa T, et al. Utility of endoscopic retrograde pancreatogram to diagnose autoimmune pancreatitis: an international, double blind, randomized, multicenter study. Gastrointest Endosc 2009; 69: AB124.
59. Kamisawa T, Tu Y, Nakajima H, Egawa N, Tsuruta K, Okamoto A,. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol 2006; 12: 2031-3.
60. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 2003; 27: 235-8.
61. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006; 32: 244-8.
62. Sandanayake N, Chapman MH, Kalaitzakis E, et al. Do steroids improve the long-term outcome of autoimmune pancreatitis. Gut 2010; 59 (4 Suppl. 1): A1.
63. Clark A, Zeman RK, Choyke PL, et al. Pancreatic pseudotumors associated with multifocal idiopathic fibrosclerosis. Gastrointest Radiol 1988; 13: 30-2.
64. Chutaputti A, Burrell MI, Boyer JL,. Pseudotumor of the pancreas associated with retroperitoneal fibrosis: a dramatic response to corticosteroid therapy. Am J Gastroenterol 1995; 90: 1155-8.
65. Erkelens GW, Vleggaar FP, Lesterhuis W, van Buuren HR, van der Werf SD,. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999; 354: 43-4.
66. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004; 99: 932-7.
67. Kamisawa T, Okamoto A,. Prognosis of autoimmune pancreatitis. J Gastroenterol 2007; 42 (Suppl. 18): 59-62.
68. Kawa S, Hamano H,. Clinical features of autoimmune pancreatitis. J Gastroenterol 2007; 42 (Suppl. 18): 9-14.
69. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007; 35: 156-61.
70. Muraki T, Hamano H, Ochi Y, et al. Autoimmune pancreatitis and complement activation system. Pancreas 2006; 32: 16-21.
71. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134: 440-6.
72. Umemura T, Ota M, Hamano H, et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 2008; 103: 588-94. (Pubitemid 351406007)
73. Weber SM, Cubukcu-Dimopulo O, Palesty JA, et al. Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003; 7: 129-37.
74. Bermejo F, Lopez-Sanroman A, Taxonera C, et al. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis. Aliment Pharmacol Ther 2008; 28: 623-8.
75. Prefontaine E, Macdonald JK, Sutherland LR,. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2009; CD000545.
76. Johnson PJ, McFarlane IG, Williams R,. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-63.
77. Hegarty JE, Nouri Aria KT, Portmann B, Eddleston AL, Williams R,. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 1983; 3: 685-9.
78. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008; 6: 364-6. (Pubitemid 351318380)
79. Rueda JC, Duarte-Rey C, Casas N,. Successful treatment of relapsing autoimmune pancreatitis in primary Sjogren's syndrome with rituximab: report of a case and review of the literature. Rheumatol Int 2009; 29: 1481-5.